Bronchial Neoplasms
Information
- Disease name
- Bronchial Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04862780 | Active, not recruiting | Phase 1/Phase 2 | (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC | June 29, 2021 | January 31, 2025 |
| NCT05241873 | Active, not recruiting | Phase 1/Phase 2 | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | March 4, 2022 | July 25, 2026 |
| NCT02493023 | Completed | N/A | Automatic CT-to-patient Registration During Navigated Bronchoscopy and EBUS | October 2011 | August 2015 |
| NCT02745002 | Completed | N/A | Navigated EBUS and Functional Imaging in Lung Cancer | April 2016 | December 31, 2023 |
| NCT02897778 | Completed | Phase 1 | Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | August 24, 2016 | March 13, 2017 |
| NCT02909452 | Completed | Phase 1 | Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | September 20, 2016 | February 9, 2021 |
| NCT03516214 | Completed | Phase 1 | EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations | April 25, 2018 | November 27, 2023 |
| NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
| NCT01261585 | Completed | Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT | December 2008 | December 2009 | |
| NCT06376084 | Not yet recruiting | Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC | July 24, 2024 | February 28, 2028 | |
| NCT06177925 | Recruiting | Phase 2 | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC | December 10, 2023 | September 30, 2026 |
| NCT02264210 | Recruiting | Phase 2 | Icotinib for Completed Resected IB NSCLC With EGFR Mutation | January 2015 | December 2025 |
| NCT03745859 | Suspended | Evaluation of a New Open Source Virtual Bronchoscope Navigation System | November 19, 2018 | October 2023 | |
| NCT02050724 | Terminated | Phase 2 | ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT | November 2013 | December 31, 2016 |
| NCT04644315 | Terminated | Phase 2 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | May 24, 2021 | May 16, 2022 |
| NCT05153408 | Terminated | Phase 1 | (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC | January 13, 2022 | December 9, 2022 |
| NCT02804100 | Unknown status | Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients | May 2016 | June 2018 | |
| NCT03402048 | Unknown status | Phase 3 | The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial | July 2012 | May 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001984